Pursuant to the terms and conditions of the License Agreement, Pieris is licensing from Enumeral specified intellectual property related to Enumeral’s anti-PD-1 antibody program ENUM 388D4 for the
The addition of Crelux provides augmented scientific depth and complements existing capabilities within the WuXi structure-based drug discovery platform. Crelux was founded in 2005 and has its laboratories
Both studies met their primary endpoints of non-inferiority to Gilead’s Viread® (tenofovir disoproxil fumarate, TDF) 300 mg based on the percentage of patients with HBV DNA levels below
The majority of the work in this contract will take place under an agreement with Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. ("Merck")
A Phase 1 clinical trial evaluating the safety, tolerability and pharmacokinetics of ganaxolone IV is expected to initiate in the first half of 2016. Marinus Pharmaceuticals CEO Christopher
This partnership is focused on developing a second generation, longer acting version of Coversin. Under this collaboration agreement, XL-protein will apply its proprietary PASylation® technology for drug half-life
Under the agreement, TGI would be Quark’s preferred provider of gene expression profiling services related to their clinical trial. The primary objective of the Quark/TGI collaboration will be
In this study, ZEPATIER demonstrated superiority on efficacy and safety endpoints compared to sofosbuvir plus pegIFN/RBV, based on pre-specified analyses. In the full analysis set (FAS) (n=255), the
ExxPharma will be responsible for technical development while Halo will have overall responsibility of drug product manufacturing and quality control at Halo’s state-of-the art GMP-compliant manufacturing facility in
Vyvanse capsules can be swallowed whole or consumed by opening and mixing the entire contents into water, orange juice or yogurt. Vyvanse chewable tablets will offer an additional
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.